Preferred Label : maralixibat;
MeSH synonym : (4R,5R)-5-(4-((4-(4-aza-1-azoniabicyclo(2.2.2)octan-1-ylmethyl)phenyl)methoxy)phenyl)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6-benzothiepin-4-ol; livmarli;
Origin ID : C000722912;
UMLS CUI : C5418448;
ATC code(s)
- Currated CISMeF NLP mapping
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3554585/fr/livmarli-maralixibat-cholestase-intrahepatique-progressive-familiale
2024
false
false
false
France
Maralixibat Chloride
maralixibat chloride
treatment outcome
insurance, health, reimbursement
infant
Progressive familial intrahepatic cholestasis
guidelines for drug use
administration, oral
evaluation of the transparency committee
cholestasis, intrahepatic
maralixibat
---
https://www.has-sante.fr/jcms/p_3500260/fr/livmarli-maralixibat-syndrome-d-alagille
2024
false
false
false
France
Cholestatic pruritus (disorder)
treatment outcome
insurance, health, reimbursement
infant
child
administration, oral
pharmaceutical solutions
maralixibat chloride
Maralixibat Chloride
cholestatic pruritus in Alagille syndrome
evaluation of the transparency committee
alagille syndrome
maralixibat
---
https://ansm.sante.fr/tableau-acces-derogatoire/maralixibat
2024
false
false
false
France
French
drug information
insurance, health, reimbursement
maralixibat
Maralixibat Chloride
administration, oral
maralixibat chloride
alagille syndrome
pruritus
Cholestatic pruritus (disorder)
---
https://ansm.sante.fr/tableau-marr/maralixibat
2024
false
false
false
France
French
risk management
maralixibat
maralixibat chloride
guidelines for drug use
patient education handout
medication errors
---
https://www.has-sante.fr/jcms/p_3418145/fr/livmarli-maralixibat-syndrome-d-alagille
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
maralixibat chloride
infant
child
Cholestatic pruritus (disorder)
administration, oral
orphan drug production
evaluation of the transparency committee
maralixibat
alagille syndrome
---
https://www.ema.europa.eu/en/medicines/human/EPAR/livmarli
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Maralixibat Chloride
Maralixibat Chloride
maralixibat chloride
maralixibat
maralixibat
infant
child
alagille syndrome
pruritus
Cholestatic pruritus (disorder)
orphan drug production
pharmaceutical solutions
administration, oral
ileal sodium-dependent bile acid transporter
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
cholestatic pruritus in Alagille syndrome
---
https://www.has-sante.fr/jcms/p_3421134/fr/livmarli-maralixibat-syndrome-d-alagille-sag
2023
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
maralixibat
alagille syndrome
Maralixibat Chloride
maralixibat chloride
infant
child
administration, oral
Cholestatic pruritus (disorder)
pruritus
pharmaceutical solutions
cholestatic pruritus in Alagille syndrome
---
